News Cabenuva Approved as First Long-Acting Injectable for HIV Treatment By Brian Park, PharmD Publish Date January 22, 2021
Drugs in the Pipeline Bamlanivimab Promising for COVID-19 Prevention in Long-Term Care Facilities By Brian Park, PharmD Publish Date January 21, 2021
News FDA: Update on Blood Donation During COVID-19 Pandemic By Brian Park, PharmD Publish Date January 20, 2021
Drugs in the Pipeline FDA Fast Tracks Brilacidin for COVID-19 Treatment By Brian Park, PharmD Publish Date January 14, 2021
Drugs in the Pipeline Phase 3 Study Evaluating Ravulizumab for COVID-19 Paused By Brian Park, PharmD Publish Date January 14, 2021
News HIV Patient’s Detectable Viremia Linked to ART-Supplement Interaction By Cassandra Pardini, PharmD Publish Date January 14, 2021
News Pfizer-BioNTech COVID-19 Vaccine Elicits Response Against Key Mutation By Diana Ernst, RPh Publish Date January 12, 2021
News Use of Direct Acting Antivirals With Potent Inducers Examined in Case Series By Cassandra Pardini, PharmD Publish Date January 11, 2021
News Majority of SARS-CoV-2 Transmission Due to Asymptomatic Individuals Publish Date January 11, 2021
Safety Alerts and Recalls FDA: SARS-CoV-2 Mutations May Impact Molecular Tests By Brian Park, PharmD Publish Date January 8, 2021
News Case Series Describes Use of Icosapent Ethyl for COVID-19 Pneumonia By Cassandra Pardini, PharmD Publish Date January 5, 2021
Safety Alerts and Recalls False Results Possible With Curative SARS-CoV-2 Test, Says FDA By Brian Park, PharmD Publish Date January 5, 2021
Safety Alerts and Recalls Counterfeit HIV Drug Identified in Three US Pharmacies By Diana Ernst, RPh Publish Date December 28, 2020